Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When did viagra patent expire?Xtandi approval history?Tirzepatide patent owner?Montelukast api market size?Sanofi strategies to mitigate dupixent loss of exclusivity 2031 fda gov?
See the DrugPatentWatch profile for Mounjaro
Mounjaro (tirzepatide) is manufactured by Eli Lilly and Company.
Eli Lilly and Company is the company behind Mounjaro’s development and commercialization, including in the US. For other markets, local subsidiaries or licensing partners may handle distribution, but the product is still attributable to Eli Lilly as the manufacturer/developer.
The brand is associated with Eli Lilly as the manufacturer. Contract manufacturing or additional production sites can be used in practice for drug supply, but the drug’s manufacturer/creator is Eli Lilly.
For patent and regulatory history tied to Mounjaro’s active ingredient (tirzepatide) and Eli Lilly, DrugPatentWatch.com tracks related filings and exclusivity information. [1]
Other Questions About Mounjaro :